<DOC>
	<DOCNO>NCT01784471</DOCNO>
	<brief_summary>This single-arm , single-center , open-label , pilot study . 30 subject foot symptom attributable diabetes peripheral vascular disease screen . Subjects meet inclusion criterion sign inform consent enrol . All 30 subject treat Magic Foot™ . If significant improvement ICG foot symptom obtain self evaluation questionnaire , 30 subject enrol .</brief_summary>
	<brief_title>Open-label Pilot Study Assess Use Magic Foot™ Improvment Parameters Subject With Foot Symptoms</brief_title>
	<detailed_description>This single-arm , single-center , open-label , pilot study . 30 subject foot symptom attributable diabetes peripheral vascular disease screen enrol . Subjects meet inclusion criterion sign inform consent . They undergo full examination include blood pressure measurement , heart rate ECG . A self evaluation questionnaire relate foot sleep disorder symptom complete . A baseline screen ICG perform measure total peripheral resistance CO ( Cardiac Output ) SV ( Stroke Volume ) . ABI perform . The investigational product use 30 minute ICG repeat . Each subject provide size appropriate pair Magic Foot™ use home . Magic Foot™ use thirty minute daily 30 day . This do rest even prior bedtime . A diary report compliance provide subject . The subject provide complete diary site staff day 14 day 30 . Subjects reassess Day 14 . Self evaluation questionnaire complete . Subjects continue daily use Magic Foot™ . Subject reassess day 30 . ICG , ABI ( Ankle Bracial Index ) final self assessment questionnaire repeat day 30 . At end study Magic Foot™ remain subject . In consultation treat physician decision make whether continue treatment .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>1 . Subject age 18 Type 1 / Type 2 diabetes PVD ( Peripheral vascular disease ) ABI &lt; 0.9 foot symptom . 2 . Subject able willing comply requirement protocol . 3 . Subject able understand sign write informed consent participate study . One follow foot symptom : Pain rest Pain activity Nocturnal foot pain Burning sensation Loss sensation Cold foot Recurrent ulcer , wound , injury longtime heal 1 . Active foot infection 2 . Open ulcer shoe area 3 . Subjects unstable lifethreatening condition 4 . History malignancy 5 . Active Charcot arthropathy 6 . Impaired cognitive function unable sign inform consent 7 . History drug alcohol abuse 8 . Subject currently enrol yet complete investigational device drug study subject receive investigational agent . 9 . Other condition base Principle Investigators judgement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Foot Symptoms</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Peripheral Vascular Disease</keyword>
	<keyword>Magic Foot shoe</keyword>
</DOC>